Trademark: 97132742
Word
EDNA
Status
Registered
Status Code
700
Status Date
Tuesday, July 25, 2023
Serial Number
97132742
Registration Number
7117958
Registration Date
Tuesday, July 25, 2023
Mark Type
4000
Filing Date
Thursday, November 18, 2021
Published for Opposition
Tuesday, May 9, 2023

Trademark Owner History
NUCLERA LTD - Original Registrant
Nuclera Nucleics Limited - Owner At Publication

Classifications
9 Scientific laboratory apparatus and instruments, namely, scientific desktop instruments for DNA, RNA, gene and protein synthesis;medical laboratory research instrument in the nature of desktop instrument cartridges for DNA, RNA, gene and protein synthesis, namely, microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors for scientific, research or industrial purposes in DNA, RNA, gene and protein synthesis; bio-chips for scientific, research or industrial purposes; scientific research and laboratory apparatus, namely, apparatus and instruments for amplifying DNA and RNA, reactors, bioreactors, and laboratory apparatus and instruments for amplifying DNA and RNA using polymerase chain reaction (PCR); apparatus and instruments for synthesizing DNA and RNA, namely, microarrays, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips; scientific research and laboratory apparatus, namely, apparatus and instruments for processing DNA and RNA, scientific desktop instruments, desktop instrument cartridges, semiconductors, semiconductor chips, microchips, bio sensors, and bio-chips; computer hardware, recorded computer software, downloadable computer software, and downloadable bioinformatics software for use in DNA, RNA, gene and protein synthesis in the fields of biotechnology and medical science
5 Pharmaceutical and veterinary preparations, namely, nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; biological, chemical and biochemical reagents, namely, biotechnologically-formed DNA and RNA, proteins, gene editing enzymes for clinical or medical use; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides, synthetic proteins for clinical or medical use; DNA and RNA products for medical use, namely, biological, chemical and biochemical reagents, proteins and gene editing enzymes; therapeutic DNA and RNA products, namely, nucleic acid sequences and chemical reagents for medical and veterinary purposes; vaccines
1 Chemical preparations for scientific purposes; chemical preparations, enzymes, gene editing enzymes, biotechnologically-formed DNA, biotechnologically-formed RNA, oligonucleotides, biotechnologically-formed genes and proteins for scientific and industrial purposes; nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNA, synthetic RNA, synthetic genes, synthetic oligonucleotides and synthetic proteins for scientific and industrial use; chemicals, reagents and enzymes for use in the preparation and creation of DNA, RNA, genes and proteins for scientific and research purposes; molecular biology research tools in the nature of biological and biochemical reagents; molecular biology research tools in the nature of chemical, biological and biochemical reagents used for the synthesis of DNA, RNA, oligonucleotides, genes and proteins for scientific and industrial purposes
10 Medical apparatus and instruments used for DNA and RNA testing and analysis and genetic testing for medical purposes; apparatus and instruments for DNA and RNA analysis, sequencing and synthesis for medical and veterinary purposes; apparatus for DNA, RNA, gene and protein synthesis for medical and veterinary purposes

Trademark Events
Jul 25, 2023
Notice Of Registration Confirmation Emailed
Jul 25, 2023
Registered-Principal Register
Jun 14, 2023
Automatic Update Of Assignment Of Ownership
May 9, 2023
Official Gazette Publication Confirmation E-Mailed
May 9, 2023
Published For Opposition
Apr 19, 2023
Notification Of Notice Of Publication E-Mailed
Apr 3, 2023
Electronic Record Review Complete
Mar 31, 2023
On Hold - Electronic Record Review Required
Mar 28, 2023
Approved For Pub - Principal Register
Mar 28, 2023
Examiner's Amendment Entered
Mar 28, 2023
Notification Of Examiners Amendment E-Mailed
Mar 28, 2023
Examiners Amendment E-Mailed
Mar 28, 2023
Examiners Amendment -Written
Mar 9, 2023
Notification Of Final Refusal Emailed
Mar 9, 2023
Final Refusal E-Mailed
Mar 9, 2023
Final Refusal Written
Feb 28, 2023
Teas/Email Correspondence Entered
Feb 27, 2023
Correspondence Received In Law Office
Feb 27, 2023
Teas Response To Office Action Received
Aug 31, 2022
Notification Of Non-Final Action E-Mailed
Aug 31, 2022
Non-Final Action E-Mailed
Aug 31, 2022
Non-Final Action Written
Aug 30, 2022
Assigned To Examiner
Nov 23, 2021
New Application Office Supplied Data Entered
Nov 22, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24